Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trial.
Vanni T, Thomé BC, Sparrow E, Friede M, Fox CB, Beckmann AM, Huynh C, Mondini G, Silveira DH, Viscondi JYK, Braga PE, Silva AD, Salomão MDG, Piorelli RO, Santos JP, Gattás VL, Lucchesi MBB, Oliveira MMM, Koike ME, Kallas EG, Campos LMA, Coelho EB, Siqueira MAM, Garcia CC, Miranda MD, Paiva TM, Timenetsky MDCST, Adami EA, Akamatsu MA, Ho PL, Precioso AR. Vanni T, et al. Among authors: miranda md. PLoS One. 2022 Oct 18;17(10):e0274943. doi: 10.1371/journal.pone.0274943. eCollection 2022. PLoS One. 2022. PMID: 36256646 Free PMC article. Clinical Trial.
Susceptibility of Brazilian influenza A(H1N1)pdm09 viruses to neuraminidase inhibitors in the 2014-2016 seasons: Identification of strains bearing mutations associated with reduced inhibition profile.
Matos AR, Resende PC, Miranda MD, Garcia CC, Caetano BC, Lopes JCO, Debur MC, Cury ALF, Vianna LA, Lima MC, Schirmer M, Gubareva L, Hurt AC, Brown DW, Siqueira MM. Matos AR, et al. Among authors: miranda md. Antiviral Res. 2018 Jun;154:35-43. doi: 10.1016/j.antiviral.2018.03.010. Epub 2018 Mar 28. Antiviral Res. 2018. PMID: 29601892
Identification of SARS-CoV-2 and additional respiratory pathogens cases under the investigation of COVID-19 initial phase in a Brazilian reference laboratory.
Matos ADR, Motta FC, Caetano BC, Ogrzewalska M, Garcia CC, Lopes JCO, Miranda M, Livorati MTFP, Abreu A, Brown D, Siqueira MM. Matos ADR, et al. Mem Inst Oswaldo Cruz. 2020 Sep 18;115:e200232. doi: 10.1590/0074-02760200232. eCollection 2020. Mem Inst Oswaldo Cruz. 2020. PMID: 32965332 Free PMC article.
Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells.
Barreto-Vieira DF, da Silva MAN, Garcia CC, Miranda MD, Matos ADR, Caetano BC, Resende PC, Motta FC, Siqueira MM, Girard-Dias W, Archanjo BS, Barth OM. Barreto-Vieira DF, et al. Among authors: miranda md. Mem Inst Oswaldo Cruz. 2021 Feb 8;116:e200443. doi: 10.1590/0074-02760200443. eCollection 2021. Mem Inst Oswaldo Cruz. 2021. PMID: 33566951 Free PMC article.
Low prevalence of influenza A strains with resistance markers in Brazil during 2017-2019 seasons.
Sousa TDC, Martins JSCC, Miranda MD, Garcia CC, Resende PC, Santos CA, Debur MDC, Rodrigues RR, Cavalcanti AC, Gregianini TS, Iani FCM, Pereira FM, Fernandes SB, Ferreira JA, Santos KCO, Motta F, Brown D, de Almeida WAF, Siqueira MM, Matos ADR. Sousa TDC, et al. Among authors: miranda md. Front Public Health. 2022 Sep 14;10:944277. doi: 10.3389/fpubh.2022.944277. eCollection 2022. Front Public Health. 2022. PMID: 36187691 Free PMC article.
66 results